Hypoglycemia surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
**Distal subtotal [[pancreatectomy]] is recommended for patients with insulinoma related to [[MEN1]].<ref name="pmid1684067">{{cite journal| author=Demeure MJ, Klonoff DC, Karam JH, Duh QY, Clark OH| title=Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. | journal=Surgery | year= 1991 | volume= 110 | issue= 6 | pages= 998-1004; discussion 1004-5 | pmid=1684067 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1684067 }}</ref> | **Distal subtotal [[pancreatectomy]] is recommended for patients with insulinoma related to [[MEN1]].<ref name="pmid1684067">{{cite journal| author=Demeure MJ, Klonoff DC, Karam JH, Duh QY, Clark OH| title=Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. | journal=Surgery | year= 1991 | volume= 110 | issue= 6 | pages= 998-1004; discussion 1004-5 | pmid=1684067 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1684067 }}</ref> | ||
* Recurrence is more common in the patients with [[MEN1]]. | * Recurrence is more common in the patients with [[MEN1]]. | ||
* Hepatic resection is indicated for the treatment of [[metastatic]] [[Liver diseases|liver disease]] if the general condition is good. Resection should be considered only for patients with a limited number of hepatic metastases.<ref name=" | * Hepatic resection is indicated for the treatment of [[metastatic]] [[Liver diseases|liver disease]] if the general condition is good. Resection should be considered only for patients with a limited number of hepatic metastases.<ref name="pmid12081066">{{cite journal| author=Hirshberg B, Libutti SK, Alexander HR, Bartlett DL, Cochran C, Livi A et al.| title=Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure. | journal=J Am Coll Surg | year= 2002 | volume= 194 | issue= 6 | pages= 761-4 | pmid=12081066 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12081066 }}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 14:04, 22 September 2017
|
Hypoglycemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypoglycemia surgery On the Web |
|
American Roentgen Ray Society Images of Hypoglycemia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]
Overview
Surgical removal of the insulinoma is the treatment of choice and resection of metastatic liver disease.
Surgery
- Surgical removal of the insulinoma is the treatment of choice:[1]
- Enucleation of the insulinoma: just removal of the mass out of the pancreas with thin margins between tumor and pancreas
- Partial distal pancreatectomy: in this procedure, the body and tail of the pancreas are removed.[2]
- Distal subtotal pancreatectomy is recommended for patients with insulinoma related to MEN1.[3]
- Recurrence is more common in the patients with MEN1.
- Hepatic resection is indicated for the treatment of metastatic liver disease if the general condition is good. Resection should be considered only for patients with a limited number of hepatic metastases.[4]
References
- ↑ Service FJ, McMahon MM, O'Brien PC, Ballard DJ (1991). "Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study". Mayo Clin Proc. 66 (7): 711–9. PMID 1677058.
- ↑ Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y; et al. (2013). "Diagnosis and management of insulinoma". World J Gastroenterol. 19 (6): 829–37. doi:10.3748/wjg.v19.i6.829. PMC 3574879. PMID 23430217.
- ↑ Demeure MJ, Klonoff DC, Karam JH, Duh QY, Clark OH (1991). "Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach". Surgery. 110 (6): 998–1004, discussion 1004-5. PMID 1684067.
- ↑ Hirshberg B, Libutti SK, Alexander HR, Bartlett DL, Cochran C, Livi A; et al. (2002). "Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure". J Am Coll Surg. 194 (6): 761–4. PMID 12081066.